Randomized double blind placebo-controlled phase II study on the effects of EA-230 on the innate immune response following on-pump cardiac surgery
- Conditions
- immune systemInflammatory repsonse1002766510038430
- Registration Number
- NL-OMON42527
- Lead Sponsor
- Exponential Biotherapies Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 160
1. Patients scheduled for elective on-pump CABG surgery, with or without valve replacement;2. Written informed consent to participate in this trial prior to any study-mandated procedure.;3. Patients aged >18 years, both male and female.;4. Patients have to agree to use a reliable way of contraception with their partners from study entry until 3 months after study drug administration.
1. Immune compromised;• Solid organ transplantation;• Known HIV;• Pregnancy;• Systemic use of immunosuppressive drugs;2. Non-elective/Emergency surgery;3. Hematological disorders;• Known disorders from myeloid and/or lymphoid origin;• Leucopenia (leucocyte count < 4x10^9/L);4. Use of iohexol contrast <48 hours before start of the first study procedure ;5. Known hypersensitivity to any excipients of the drug formulations used;6. Treatment with investigational drugs or participation in any other intervention clinical trial within 30 days prior to study drug administration;7. Inability to personally provide written informed consent (e.g. for linguistic or mental reasons) ;8. Known or suspected of not being able to comply with the trial protocol.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Safety:<br /><br>• Adverse events<br /><br>• Vital signs (blood pressure and heart rate)<br /><br>• Safety laboratory parameters (Hb, Ht, leucocytes, thrombocytes, leucocyte<br /><br>differential blood count, sodium, potassium, creatinine, urea, alkaline<br /><br>phosphatase, ALT, AST, γGT, CK, CRP)</p><br>
- Secondary Outcome Measures
Name Time Method